A First-In-Human Study of LY3839840 in Healthy Participants

Recruiting

Phase 1

LY3839840A First-In-Human Study of LY3839840 in Healthy Participants

Sponsor:

Eli Lilly and Company

Code:

NCT06153355

Conditions

Healthy

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Accepted

Interventions

LY3839840

Placebo

Midazolam

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Eli Lilly and Company on 2025-03-20.